1. Patel M., Antala B., Shrivastava N. (2015) In silico screening of alleged miRNAs associated with cell competition: An emerging cellular event in cancer. Cellular and Molecular Biology Letters, 20(5) 798-815. 10.1515/cmble-2015-0046
  2. Dash R.P., Ellendula B., Agarwal M., Nivsarkar M. (2015) Increased intestinal P-glycoprotein expression and activity with progression of diabetes and its modulation by epigallocatechin-3-gallate: Evidence from pharmacokinetic studies. European Journal of Pharmacology, 767(67), 76 10.1016/j.ejphar.2015.10.009
  3. Makwana V., Jain R., Patel K., Nivsarkar M., Joshi A. (2015) Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach. International Journal of Pharmaceutics, 495(1) 439-446. 10.1016/j.ijpharm.2015.09.014
  4. Patel D.N., Kalia K. (2015) Efficacy of urinary N-acetyl-β-D-glucosaminidase to evaluate early renal tubular damage as a consequence of type 2 diabetes mellitus: a cross-sectional study. International Journal of Diabetes in Developing Countries, 35, 449-457 10.1007/s13410-015-0404-2
  5. Sagar S.R., Agarwal J.K., Pandya D.H., Dash R.P., Nivsarkar M., Vasu K.K. (2015)   Design, synthesis and biological evaluation of novel pyrazolo-pyrimidinones as DPP-IV inhibitors in diabetes. Bioorganic and Medicinal Chemistry Letters, 25(20)4428-4433. 10.1016/j.bmcl.2015.09.015
  6. Shah B., Khunt D., Bhatt H., Misra M., Padh H. (2015) Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: Effect on formulation and characterization parameters. European Journal of Pharmaceutical Sciences, 78, 54-66. 10.1016/j.ejps.2015.07.002
  7. Bharvada E., Shah V., Misra M. (2015) Exploring mixing uniformity of a pharmaceutical blend in a high shear mixture granulator using enthalpy values obtained from DSC. Powder Technology, 276, 103-111. 10.1016/j.powtec.2015.02.008
  8. Patil D., Dash R.P., Thakur S.K., Pandya A.N., Venkatesh P., Vasu K.K., Nivsarkar M. (2015) Implication of novel thiazolo-thiophene derivative (MCD-KV-10) for management of asthma Journal of Enzyme. Inhibition and Medicinal Chemistry, 30(2) 229-239. 10.3109/14756366.2014.913035
  9. Mahapatra A., Shah P., Jivrajani M., Nivsarkar M. (2015) Synthesis and blastocyst implantation inhibition potential of lupeol derivatives in female mice. Records of Natural Products,9(4) 561-566
  10. Rathee D., Rathee S., Rathee P., Deep A., Anandjiwala S., Rathee D. (2015) HPTLC densitometric quantification of stigmasterol and lupeol from Ficus religiosa. Arabian Journal of Chemistry, 8,(3) 366-371. 10.1016/j.arabjc.2011.01.021
  11. Tambe P., Purohit I., Suneja D., More S., Desai P., Shrivastava N. (2015) The shRNA-mediated silencing of VEGF-C illustrates its role in proliferation, chemosensitization, tumor colonization, and anchorage independence. Biotechnologia, 96(3), 225-233. 10.5114/bta.2015.56572
  12. Patel M., Antala B., Shrivastava N. (2015) Cell competition: Roles and importance as a central phenomenon. Critical Reviews in Eukaryotic Gene Expression, 25 (4) 307-314 10.1615/CritRevEukaryotGeneExpr.2015014029
  13. Shah S., Shah S., Padh H., Kalia K. (2015) Genetic alterations of the PIK3CA oncogene in human oral squamous cell carcinoma in an Indian population. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 120(5), 628-635. 10.1016/j.oooo.2015.08.003
  14. Shah B.M., Misra M., Shishoo C.J., Padh H. (2015) Nose to brain microemulsion-based drug delivery system of rivastigmine: Formulation and ex-vivo characterization. Drug Delivery,22(7), 918-930. 10.3109/10717544.2013.878857
  15. Dokania S., Joshi A.K. (2015) Self-microemulsifying drug delivery system (SMEDDS)-challenges and road ahead. Drug Delivery, 22(6), 675-690. 10.3109/10717544.2014.896058